Comparative validation of prognostic rules for community-acquired pneumonia in an elderly population

The aim of the study was to validate the prediction rule of M.J. Fine and c oworkers for clinical outcome variables and three prognostic rules for the individual outcome of community-acquired pneumonia in an elderly population (rule 1: respiratory frequency greater than or equal to 30 breaths min(-1) , diastolic blood pressure less than or equal to 60 mmHg, blood urea nitrog en >7 mM; rule 2: respiratory frequency greater than or equal to 30 breaths .min(-1), diastolic blood pressure less than or equal to 60 mmHg, mental co nfusion; and rule 3: systolic blood pressure less than or equal to 80 mmHg, cardiac frequency greater than or equal to 90 beats.min(-1), lactate dehyd rogenase activity >260 IU.L-1; death was predicted in the presence of at le ast two of three parameters). Overall 168 consecutive episodes of community-acquired pneumonia in patient s aged greater than or equal to 65 yrs and hospitalized in a primary care h ospital were studied prospectively. Fine's rule was tested for its ability to predict length of hospital stay, requirement for intensive care unit (IC U) admission and death. For the three prognostic rules of individual outcom e, performance regarding predicting death was determined. Mortality was 17/168 (10%), Fine's rule accurately predicted length of stay , the requirement for ICU admission and the risk of death from pneumonia as compared to the original derivation and validation cohorts. All three rule s achieved moderate-to-high specificity (73%, 88% and 80%, respectively) an d high negative predictive values (95%, 94% and 93%, respectively) but had a low sensitivity (65%, 47% and 47%, respectively). Rule 2 most closely ref lected the risk of death from pneumonia when Fine's classification was used as reference. Fine's rule proved to give valid estimations regarding clinical outcome var iables of community-acquired pneumonia in the elderly The prognostic rules may be useful in determining individual patients at lower risk of death cau sed by pneumonia.